Phase I Active Immunotherapy With Combination of Two...

Journal of Clinical Oncology 2009 / 11 Vol. 27; Iss. 31

Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors

Kaumaya, P. T.P., Foy, K. C., Garrett, J., Rawale, S. V., Vicari, D., Thurmond, J. M., Lamb, T., Mani, A., Kane, Y., Balint, C. R., Chalupa, D., Otterson, G. A., Shapiro, C. L., Fowler, J. M., Grever,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2009.22.3883
Date:
November, 2009
File:
PDF, 217 KB
english, 2009
Conversion to is in progress
Conversion to is failed